Division of Pediatric Nephrology, Mubarak Al-Kabeer Hospital and Hamid Al-Essa Organ Transplant Center, Jabriya, Kuwait.
Division of Pediatric Nephrology, Rady Children's Hospital, San Diego, California.
Clin J Am Soc Nephrol. 2018 Nov 7;13(11):1721-1729. doi: 10.2215/CJN.02440218. Epub 2018 Sep 21.
AKI is associated with progression of CKD. Little is known about AKI after kidney transplantation in pediatric recipients. We aim to describe the epidemiology, risk factors, consequences, and outcomes of AKI in this population.
DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We performed a retrospective longitudinal analysis of pediatric kidney transplant recipients followed at The Hospital for Sick Children (Toronto, Canada) from 2001 to 2012. AKI was defined as an increase in serum creatinine ≥1.5 times baseline, and a rise of serum creatinine ≥1.25 but <1.5 times baseline defined subacute AKI.
Of 179 children, 122 were eligible for analysis. At baseline (3 months post-transplant), median age of the children was 13 years old (interquartile range, 9-16 years old), and 53% had CKD stage 2. Congenital anomalies of the kidney and urinary tract accounted for 46% of children. Over the study period (12 years), the incidence of AKI was 37% (=45 children), and 65% (79 children) experienced subacute AKI. Twenty-seven percent (33 children) did not develop AKI or subacute AKI. The main causes of AKI were infections other than urinary tract infections, rejection, and urinary tract infections. In a multivariable Poisson regression analysis, independent risk factors for AKI included younger age, girls, grafts from deceased donors, and lower baseline eGFR. AKI was significantly associated with lower long-term GFR and graft loss independent of rejection episodes. Moreover, subacute AKI was associated with progression of CKD.
AKI and subacute AKI were common after pediatric kidney transplantation, and they were associated with graft loss, lower eGFR, and more rapid progression of CKD.
急性肾损伤(AKI)与慢性肾脏病(CKD)的进展有关。对于儿童肾移植受者发生 AKI 的情况,人们知之甚少。本研究旨在描述该人群中 AKI 的流行病学、危险因素、后果和结局。
设计、设置、参与者和测量:我们对 2001 年至 2012 年在加拿大多伦多 SickKids 医院接受治疗的儿童肾移植受者进行了回顾性纵向分析。AKI 的定义为血清肌酐升高≥基础值的 1.5 倍,血清肌酐升高≥基础值的 1.25 倍但<1.5 倍定义为亚急性 AKI。
在 179 名儿童中,有 122 名符合分析条件。在基线(移植后 3 个月)时,儿童的中位年龄为 13 岁(四分位间距为 9-16 岁),53%患有 CKD 2 期。肾脏和泌尿道先天畸形占儿童的 46%。在研究期间(12 年),AKI 的发生率为 37%(=45 名儿童),65%(79 名儿童)发生亚急性 AKI。27%(33 名儿童)未发生 AKI 或亚急性 AKI。AKI 的主要原因是除泌尿道感染以外的感染、排斥反应和泌尿道感染。在多变量泊松回归分析中,AKI 的独立危险因素包括年龄较小、女孩、来自已故供者的移植物和较低的基线 eGFR。AKI 与排斥反应无关,与较低的长期 GFR 和移植物丢失显著相关。此外,亚急性 AKI 与 CKD 的进展有关。
儿童肾移植后 AKI 和亚急性 AKI 很常见,与移植物丢失、较低的 eGFR 和 CKD 更快进展有关。